REGISTER: NCCN Heme Malignancies Annual Congress (10.6 to 10.7.17)

September 5, 2017
By: Julie Poucher Harbin, Writer, DCI

The National Comprehensive Cancer Network (NCCN) will host its 12th Annual Congress: Hematologic Malignancies on Friday, Oct. 6, and Saturday, Oct. 7, at the Hilton San Francisco Union Square. 

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

This year's congress will kick off with registration, exhibits, and refreshments on Friday, followed by educational sessions starting at 6 p.m.. The congress will end at 5 p.m. on Saturday.  

The speakers list includes Duke Cancer Institute member, hematologic oncologist Thomas Leblanc, MD, who will speak on "Palliative and End of Life Care in Hematological Malignancies." 

REGISTER

*AGENDA 

Friday, October 6, 2017 

4:30 PM 

Registration Desk Opens

4:30 - 6:00 PM 

Refreshments and Exhibits

6:00 - 6:15 PM

Opening Remarks
Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

6:15 - 6:40 PM

WHO Classification of Lymphoma: A Clinician’s Perspective 
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

6:45 - 7:10 PM

Updates on the Treatment of Follicular Lymphoma 
Jane N. Winter, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

7:15 - 7:40 PM

New Options for the Management of Hodgkin Lymphoma
Ranjana H. Advani, MD
Stanford Cancer Institute

7:45 - 8:35 PM

Patient Case Studies and Panel Discussion: Lymphoma
M
oderator: 
Ranjana H. Advani, MD
Stanford Cancer Institute

Panelists: 
Mark W. Clemens, II, MD
The University of Texas MD Anderson Cancer Center

Youn H. Kim, MD
Stanford Cancer Institute

Jane N. Winter, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

 

Saturday, October 7, 2017

7:00 - 8:00 AM

Breakfast and Exhibits

8:00 - 8:05 AM

Opening Remarks
Ranjana H. Advani, MD 
Stanford Cancer Institute
                                    
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

8:05 - 8:45 AM

Managing Lymphoma Survivors 
Sharyn L. Kurtz, PA-C, MPAS, MA
Dana-Farber Cancer Institute

8:50 - 9:40 AM

Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
Moderator: 
Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

Panelists: 
Natalie S. Callander, MD
University of Wisconsin Carbone Cancer Center

Shaji K. Kumar, MD
Mayo Clinic Cancer Center

Sandy W. Wong, MD
UCSF Helen Diller Family Comprehensive Cancer Center

9:45 - 10:10 AM

Management of Newly Diagnosed Multiple Myeloma in Those Eligible for Transplant
Shaji K. Kumar, MD
Mayo Clinic Cancer Center

10:10 - 10:40 AM

Break and Exhibits

10:40 - 11:05 AM

Treatment of Relapsed/Refractory Multiple Myeloma
Natalie S. Callander, MD
University of Wisconsin Carbone Cancer Center

11:10 - 11:35 AM

Management of Common Complications Related to Multiple Myeloma and its Treatment
Kathleen Colson, RN, BSN, BS
Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center 

11:40 - 12:05 PM

Palliative and End of Life Care in Hematological Malignancies 
Thomas W. LeBlanc, MD, MA, MHS
Duke Cancer Institute

12:05 - 1:05 PM

Lunch and Exhibits

1:05 - 1:55 PM

Patient Case Studies and Panel Discussion: Leukemia
Moderator: 
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Panelists:
Ruben A. Mesa, MD
Mayo Clinic Cancer Center

Neil P. Shah, MD, PhD
UCSF Helen Diller Family Comprehensive Cancer Center

William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

2:00 - 2:25 PM

Myeloproliferative Neoplasms: 
Management of Polycythemia Vera and Essential Thrombocythemia
Ruben A. Mesa, MD
UT Health San Antonio Cancer Center

2:30 - 2:55 PM

How to Sequence Therapy in Chronic Lymphocytic Leukemia
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

3:00 - 3:25 PM

New Therapeutic Agents and Considerations in the 
Management of Acute Lymphocytic Leukemia
David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

3:25 - 3:50 PM

Break and Exhibits

3:50 - 4:15 PM

Targeted Therapy for Acute Myeloid Leukemia
Bruno C. Medeiros, MD
Stanford Cancer Institute

4:20 - 5:00 PM

Controversies in Acute Myeloid Leukemia: 
Is Monitoring Minimal Residual Disease Clinically Relevant?
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
                                    
Richard M. Stone, MD
Dana-Farber Cancer Institute

5:00 PM 

Closing Remarks
Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Last updated June 21, 2017

*This agenda is subject to change. Faculty will be updated as confirmed.